IJMS manuscript!


Congratulations to Jakub on his first first-author manuscript published in Int J Mol Sci, where he showed that compared to hydroxamates, the oxadizole zinc-binding group contributes markedly to exquisite selectivity of small molecule inhibitors for HDAC6. Thanks also go to our long-term collaborators from the IOCB (Prague, Czech Republic) and Starwise Therapeutics (Madison, USA).